Morgan Ashurst undertook the design and construction of one of Europe’s most technically advanced pharmaceutical development facilities. The state-of-the-art facility is dedicated to providing supplies of potential new medicines for world-wide clinical trials and to developing the manufacturing processes required for eventual transfer to large-scale production.
The new facility has been integrated, physically and functionally, with the new Pharmaceutical and Analytical Laboratory building (PAL) which was also designed and constructed by Morgan Ashurst.
